Islamabad witnessed a significant development in the ongoing medical treatment of Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan, who underwent his third intravitreal anti-VEGF injection on Monday at the Pakistan Institute of Medical Sciences (PIMS). This procedure is part of a carefully monitored treatment plan aimed at addressing his serious eye condition, which has been a cause of concern for both his supporters and medical professionals alike.
Imran Ahmed Khan Niazi, aged 74, was admitted to PIMS on March 23, 2026, specifically for this third dose of the injection. Prior to the procedure, a thorough examination was conducted by a team of ophthalmologists to assess his overall health and the status of his vision. Medical staff confirmed that he was vitally stable, allowing the treatment to proceed without any complications. The injection was administered in a controlled operating theatre environment, following all necessary protocols and safety measures to ensure the highest standard of care.
The surgical team performed the injection under microscopic guidance, a technique that enhances precision and reduces risks during such delicate eye procedures. PIMS officials emphasized that this intervention was carried out as a day-care surgery, meaning that Imran Khan did not require overnight hospitalization. Throughout the entire process, from pre-operation to post-operation, his vital signs remained stable, reflecting a positive response to the ongoing treatment regimen. After the procedure, he was discharged with detailed instructions for post-treatment care and scheduled follow-up appointments to monitor his recovery closely.
Imran Khan’s eye ailment, diagnosed as right central retinal vein occlusion (CRVO), first came to light in late January. This condition involves a blockage of the central retinal vein, which can lead to sudden and severe vision loss. A report submitted to the court by Barrister Salman Safdar highlighted the gravity of the situation, stating that the PTI leader had lost approximately 85 percent of vision in his right eye. The report also mentioned that Imran Khan had requested evaluations by renowned ophthalmologists Dr. Faisal Sultan and Dr. Asim Yousuf to further understand the extent of his condition and explore treatment options.
Moreover, the legal submission underscored the necessity for expert ophthalmological consultation to manage his deteriorating eyesight effectively. It also brought attention to the challenges faced by Imran Khan during his solitary confinement, noting his lack of access to basic amenities such as television and books, which were requested to help alleviate the isolation. The report criticized jail authorities for their inadequate response to his health concerns over the past three months, alleging negligence in addressing the progressive loss of his vision.
Despite these difficulties, the recent medical interventions at PIMS demonstrate a concerted effort to stabilize and potentially improve Imran Khan’s eye health. The continuation of anti-VEGF injections represents a critical component of his treatment, aiming to reduce swelling and prevent further vision loss. Medical experts remain cautiously optimistic, stressing the importance of ongoing monitoring and timely follow-ups to adapt the treatment plan as needed.
As the situation unfolds, the public and political circles continue to watch closely, given the former prime minister’s prominent role in Pakistan’s political landscape. His health status not only affects his personal well-being but also has broader implications for his political activities and leadership within PTI. The coming weeks will be crucial in determining the effectiveness of the treatment and the potential for recovery of his vision.
